ロード中...
Liquid Biopsy to Identify Actionable Genomic Alterations
Liquid biopsy has been used extensively in solid malignancies to detect actionable driver mutations, to monitor treatment response, to detect recurrence, to identify resistance mechanisms, and to prognosticate outcome. Although many liquid biopsy sequencing platforms are being used, only five test k...
保存先:
| 出版年: | Am Soc Clin Oncol Educ Book |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6865813/ https://ncbi.nlm.nih.gov/pubmed/30231331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EDBK_199765 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|